190 related articles for article (PubMed ID: 18241231)
1. Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy.
Landrø L; Damås JK; Flo TH; Heggelund L; Ueland T; Tjønnfjord GE; Espevik T; Aukrust P; Frøland SS
Clin Exp Immunol; 2008 Apr; 152(1):57-63. PubMed ID: 18241231
[TBL] [Abstract][Full Text] [Related]
2. Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.
Theodoridou K; Margeli A; Spoulou V; Bathrellou I; Skevaki C; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
Scand J Clin Lab Invest; 2014 Jan; 74(1):67-73. PubMed ID: 24266781
[TBL] [Abstract][Full Text] [Related]
3. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
4. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.
Hunt PW; Deeks SG; Rodriguez B; Valdez H; Shade SB; Abrams DI; Kitahata MM; Krone M; Neilands TB; Brand RJ; Lederman MM; Martin JN
AIDS; 2003 Sep; 17(13):1907-15. PubMed ID: 12960823
[TBL] [Abstract][Full Text] [Related]
5. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen.
Allavena C; Bach-Ngohou K; Billaud E; Sécher S; Dejoie T; Reliquet V; Fakhouri F; Raffi F
J Antimicrob Chemother; 2013 Dec; 68(12):2866-70. PubMed ID: 23818285
[TBL] [Abstract][Full Text] [Related]
7. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of neutrophil gelatinase-associated lipocalin in Crimean-Congo hemorrhagic Fever.
Erturk A; Cure E; Parlak E; Cumhur Cure M; Baydur Sahin S; Yuce S
Biomed Res Int; 2015; 2015():374010. PubMed ID: 25685783
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy.
Anselmi A; Vendrame D; Rampon O; Giaquinto C; Zanchetta M; De Rossi A
Clin Exp Immunol; 2007 Dec; 150(3):442-50. PubMed ID: 17956580
[TBL] [Abstract][Full Text] [Related]
10. Peripheral monocytes derived from patients with cystic fibrosis and healthy donors secrete NGAL in response to Pseudomonas aeruginosa infection.
Zughaier SM; Tangpricha V; Leong T; Stecenko AA; McCarty NA
J Investig Med; 2013 Aug; 61(6):1018-25. PubMed ID: 23838697
[TBL] [Abstract][Full Text] [Related]
11. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy.
Yokozaki S; Takamatsu J; Nakano I; Katano Y; Toyoda H; Hayashi K; Hayakawa T; Fukuda Y
Blood; 2000 Dec; 96(13):4293-9. PubMed ID: 11110704
[TBL] [Abstract][Full Text] [Related]
12. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
13. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
14. Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia.
Aboulafia DM; Bundow D; Waide S; Bennet C; Kerr D
Am J Med Sci; 2000 Aug; 320(2):117-23. PubMed ID: 10981487
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection.
Ormaasen V; Bruun JN; Sandvik L; Holberg-Petersen M; Gaarder PI
Scand J Infect Dis; 2003; 35(6-7):383-8. PubMed ID: 12953949
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study.
Erb P; Battegay M; Zimmerli W; Rickenbach M; Egger M
Arch Intern Med; 2000 Apr; 160(8):1134-40. PubMed ID: 10789606
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm.
Ramos-Mozo P; Madrigal-Matute J; Vega de Ceniga M; Blanco-Colio LM; Meilhac O; Feldman L; Michel JB; Clancy P; Golledge J; Norman PE; Egido J; Martin-Ventura JL
Atherosclerosis; 2012 Feb; 220(2):552-6. PubMed ID: 22169111
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
[TBL] [Abstract][Full Text] [Related]
20. Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication.
Damås JK; Landrø L; Fevang B; Heggelund L; Tjønnfjord GE; Fløisand Y; Halvorsen B; Frøland SS; Aukrust P
Clin Exp Immunol; 2009 Sep; 157(3):400-7. PubMed ID: 19664149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
